DrugCite
Search

THEO DUR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Theo Dur Adverse Events Reported to the FDA Over Time

How are Theo Dur adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Theo Dur, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Theo Dur is flagged as the suspect drug causing the adverse event.

Most Common Theo Dur Adverse Events Reported to the FDA

What are the most common Theo Dur adverse events reported to the FDA?

Hypokalaemia
11 (2.35%)
Nausea
11 (2.35%)
Rhabdomyolysis
10 (2.13%)
Alanine Aminotransferase Increased
9 (1.92%)
Blood Lactate Dehydrogenase Increas...
9 (1.92%)
Chest Pain
9 (1.92%)
Drug Interaction
8 (1.71%)
Hepatic Function Abnormal
8 (1.71%)
Aspartate Aminotransferase Increase...
7 (1.49%)
Convulsion
7 (1.49%)
Liver Disorder
7 (1.49%)
Show More Show More
Drug Ineffective
6 (1.28%)
Drug Toxicity
6 (1.28%)
Pneumonia
6 (1.28%)
Vomiting
6 (1.28%)
Abdominal Pain
5 (1.07%)
Anorexia
5 (1.07%)
Blood Pressure Decreased
5 (1.07%)
Delirium
5 (1.07%)
Dyspnoea
5 (1.07%)
Fatigue
5 (1.07%)
Lymphocyte Stimulation Test Positiv...
5 (1.07%)
Agranulocytosis
4 (.85%)
Atrial Fibrillation
4 (.85%)
Blood Alkaline Phosphatase Increase...
4 (.85%)
Blood Creatine Phosphokinase Increa...
4 (.85%)
Blood Urea Increased
4 (.85%)
Dehydration
4 (.85%)
Loss Of Consciousness
4 (.85%)
Muscular Weakness
4 (.85%)
Stomatitis
4 (.85%)
Abnormal Behaviour
3 (.64%)
Arthritis
3 (.64%)
Cardio-respiratory Arrest
3 (.64%)
Chest Discomfort
3 (.64%)
Condition Aggravated
3 (.64%)
Depressed Level Of Consciousness
3 (.64%)
Drug Exposure During Pregnancy
3 (.64%)
Electrocardiogram St Segment Elevat...
3 (.64%)
Haematochezia
3 (.64%)
Haemolytic Anaemia
3 (.64%)
Hepatic Enzyme Increased
3 (.64%)
Hepatitis
3 (.64%)
Hyperuricaemia
3 (.64%)
Intentional Overdose
3 (.64%)
Intestinal Ischaemia
3 (.64%)
Intestinal Obstruction
3 (.64%)
Jaundice
3 (.64%)
Laboratory Test Abnormal
3 (.64%)
Overdose
3 (.64%)
Pain
3 (.64%)
Polydactyly
3 (.64%)
Pyrexia
3 (.64%)
Respiratory Alkalosis
3 (.64%)
Somnolence
3 (.64%)
Suicide Attempt
3 (.64%)
Amnesia
2 (.43%)
Angle Closure Glaucoma
2 (.43%)
Asthma
2 (.43%)
Back Pain
2 (.43%)
Basophil Count Increased
2 (.43%)
Blood 1,25-dihydroxycholecalciferol...
2 (.43%)
Blood Creatine Phosphokinase Mb Inc...
2 (.43%)
Blood Parathyroid Hormone Increased
2 (.43%)
Bone Disorder
2 (.43%)
Bronchitis
2 (.43%)
Cardiac Arrest
2 (.43%)
Cardiac Failure Acute
2 (.43%)
Confusional State
2 (.43%)
Coordination Abnormal
2 (.43%)
Copper Deficiency
2 (.43%)
Crying
2 (.43%)
Drug Eruption
2 (.43%)
Drug Hypersensitivity
2 (.43%)
Dysgeusia
2 (.43%)
Dysstasia
2 (.43%)
Electrocardiogram Change
2 (.43%)
Electrolyte Imbalance
2 (.43%)
Fanconi Syndrome
2 (.43%)
Febrile Neutropenia
2 (.43%)
Gamma-glutamyltransferase Increased
2 (.43%)
Grand Mal Convulsion
2 (.43%)
Haematuria
2 (.43%)
Haemodialysis
2 (.43%)
Headache
2 (.43%)
Hordeolum
2 (.43%)
Hypereosinophilic Syndrome
2 (.43%)
Hyperglycaemia
2 (.43%)
Hypophosphataemia
2 (.43%)
Hypovolaemia
2 (.43%)
Interstitial Lung Disease
2 (.43%)
Leukocytosis
2 (.43%)
Liver Function Test Abnormal
2 (.43%)
Lymphocyte Count Increased
2 (.43%)
Monocyte Count Increased
2 (.43%)
Musculoskeletal Stiffness
2 (.43%)
Myocardial Infarction
2 (.43%)
Osteomalacia
2 (.43%)
Pain In Extremity
2 (.43%)
Palpitations
2 (.43%)
Parosmia
2 (.43%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Theo Dur, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Theo Dur is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Theo Dur

What are the most common Theo Dur adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Theo Dur, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Theo Dur is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Theo Dur According to Those Reporting Adverse Events

Why are people taking Theo Dur, according to those reporting adverse events to the FDA?

Asthma
316
Drug Use For Unknown Indication
77
Product Used For Unknown Indication
76
Chronic Obstructive Pulmonary Disea...
60
Emphysema
41
Bronchitis
18
Show More Show More
Bronchitis Chronic
16
Cough
11
Hypersensitivity
8
Dyspnoea
7
Bronchiectasis
7
Ill-defined Disorder
4
Cardiac Asthma
4
Pneumonia
4
Analgesic Asthma Syndrome
3
Prophylaxis
3
Bronchopneumopathy
3
Chronic Obstructive Airways Disease
3
Apnoeic Attack
2
Infantile Asthma
2
Interstitial Lung Disease
2
Chronic Respiratory Failure
2
Bronchial Disorder
2
Sputum Retention
2
Cardiac Failure Congestive
1
Metastases To Lung
1
Obstructive Airways Disorder
1
Influenza
1
Stridor
1
Respiratory Disorder
1
Wheezing
1
Cor Pulmonale Chronic
1
Lung Disorder
1

Theo Dur Case Reports

What Theo Dur safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Theo Dur. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Theo Dur.